Explore new advanced technology solutions for the biomanufacturing of cell, gene and extracellular vesicle therapies
Attending BPI 2019? Be sure to stop by booth #1507 to:
• Learn how to radically simplify the use of human mesenchymal stem/stromal cells (hMSCs) and extracellular vesicles (EVs) with RoosterBio’s next-gen technologies
• Ask us about our new umbilical cord-derived (hUC) MSC product
• Receive some RoosterSwag while supplies last
Join us for talks and poster presentations that include strategies and solutions for rapidly streamlining the path to clinical manufacturing
September 9, 2019 (Pre-Conference Workshop at Cell & Gene Therapy Meeting)
10:00am
“Radically Simplifying Scale-Up of hMSCs” under the Tissue track and Next Generation Tools for Manufacturing Medicine Products at Scale
Dr. Taby Ahsan, VP of Analytical, Product & Process Development, RoosterBio
September 10, 2019 (Cell & Gene Therapy Meeting)
11:55am
“Exosomes and Their Potential for Scalable Manufacturing Platforms” under the Exosomes track and the Pre-Clinical and Clinical Development for Cell, Gene and CAR-T Therapies
Dr. Jon A. Rowley, Founder & Chief Product Officer, RoosterBio
B24
Scaling a Xeno-Free Fed-Batch Microcarrier Suspension Bioreactor System to the Production Scale (50L) for Manufacturing XF hMSCs (Download)
B26
MSC-EVs Manufactured in Scalable 3D Bioreactor Systems (Download)
